Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer

Auteurs

Kenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, Tricia Bal, Ezra E. W. Cohen, Kevin Harrington, Denis Soulières, Christophe Le Tourneau, Lisa Licitra, Barbara Burtness, Ramona Swaby